{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:15:24Z","timestamp":1789398924527,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaesthesia Critical Care & Pain Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.accpm.2024.101445","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:24:59Z","timestamp":1729077899000},"page":"101445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study"],"prefix":"10.1016","volume":"43","author":[{"given":"Chang-Hoon","family":"Koo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soowon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subin","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-3140","authenticated-orcid":false,"given":"Yu Kyung","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-752X","authenticated-orcid":false,"given":"Insun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-6171","authenticated-orcid":false,"given":"Ah-Young","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.accpm.2024.101445_bib0005","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.3390\/jcm10153202","article-title":"Estimated incidence of sugammadex-induced anaphylaxis using the Korea adverse event reporting system database","volume":"10","author":"Ju","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.accpm.2024.101445_bib0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/ALN.0000000000004174","article-title":"Quantitative neuromuscular monitoring in clinical practice: a professional practice change initiative","volume":"136","author":"Weigel","year":"2022","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2024.101445_bib0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1213\/01.ane.0000244594.63318.fc","article-title":"Sugammadex: another milestone in clinical neuromuscular pharmacology","volume":"104","author":"Naguib","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2024.101445_bib0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/EJA.0000000000001769","article-title":"Peri-operative management of neuromuscular blockade: a guideline from the European Society of Anaesthesiology and Intensive Care","volume":"40","author":"Fuchs-Buder","year":"2023","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.accpm.2024.101445_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/ALN.0000000000004379","article-title":"2023 American Society of Anesthesiologists practice guidelines for monitoring and antagonism of neuromuscular blockade: a report by the American Society of Anesthesiologists Task Force on neuromuscular blockade","volume":"138","author":"Thilen","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2024.101445_bib0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/ALN.0000000000004044","article-title":"Quantitative neuromuscular monitoring and postoperative outcomes: a narrative review","volume":"136","author":"Murphy","year":"2022","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2024.101445_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1213\/ANE.0000000000005925","article-title":"Pro-con debate: do we need quantitative neuromuscular monitoring in the era of sugammadex?","volume":"135","author":"Blobner","year":"2022","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2024.101445_bib0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/EJA.0000000000001157","article-title":"Postoperative residual neuromuscular blockade after reversal based on a qualitative peripheral nerve stimulator response: a randomised controlled trial","volume":"37","author":"Lee","year":"2020","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.accpm.2024.101445_bib0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1213\/ANE.0b013e3182999672","article-title":"Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block","volume":"117","author":"Kotake","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2024.101445_bib0050","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/EJA.0000000000000132","article-title":"Delayed recurarisation after sugammadex reversal","volume":"31","author":"Bellod","year":"2014","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.accpm.2024.101445_bib0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/bja\/aev104","article-title":"Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomised, controlled study","volume":"115","author":"Brueckmann","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.accpm.2024.101445_bib0060","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s12630-020-01695-4","article-title":"A randomised-controlled trial of sugammadex versus neostigmine: impact on early postoperative strength","volume":"67","author":"Abola","year":"2020","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.accpm.2024.101445_bib0065","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bja.2020.01.016","article-title":"Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery","volume":"124","author":"Togioka","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.accpm.2024.101445_bib0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/ALN.0000000000004578","article-title":"A dose-finding study of sugammadex for reversal of rocuronium in cardiac surgery patients and postoperative monitoring for recurrent paralysis","volume":"139","author":"Bowdle","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2024.101445_bib0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s12630-011-9554-y","article-title":"Recurarization after sugammadex reversal in an obese patient","volume":"58","author":"Le Corre","year":"2011","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.accpm.2024.101445_bib0080","first-page":"1","article-title":"Recurarization following adequate dose of sugammadex reversal in a patient monitored with aceleromyography","volume":"36","author":"Iga","year":"2016","journal-title":"J Jpn Soc Clin Anesth"},{"key":"10.1016\/j.accpm.2024.101445_bib0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.200512-1862OC","article-title":"The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade","volume":"175","author":"Eikermann","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.accpm.2024.101445_bib0090","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jamcollsurg.2017.04.013","article-title":"Predictors of 30-day pulmonary complications after outpatient surgery: relative importance of body mass index weight classifications in risk assessment","volume":"225","author":"De Oliveira","year":"2017","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.accpm.2024.101445_bib0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.17085\/apm.21014","article-title":"The latest trend in neuromuscular monitoring: return of the electromyography","volume":"16","author":"Lee","year":"2021","journal-title":"Anesth Pain Med"},{"key":"10.1016\/j.accpm.2024.101445_bib0100","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1213\/ANE.0000000000000757","article-title":"The RECITE study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade","volume":"121","author":"Fortier","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2024.101445_bib0105","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1213\/01.ANE.0000151159.55655.CB","article-title":"Residual paralysis at the time of tracheal extubation","volume":"100","author":"Murphy","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2024.101445_bib0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1213\/ANE.0000000000002670","article-title":"Consensus statement on perioperative use of neuromuscular monitoring","volume":"127","author":"Naguib","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2024.101445_bib0115","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/aas.14279","article-title":"Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: the 2023 Geneva revision","volume":"67","author":"Fuchs-Buder","year":"2023","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["Anaesthesia Critical Care & Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556824001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556824001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T20:56:46Z","timestamp":1732222606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352556824001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2352556824001036"],"URL":"https:\/\/doi.org\/10.1016\/j.accpm.2024.101445","relation":{},"ISSN":["2352-5568"],"issn-type":[{"value":"2352-5568","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Anaesthesia Critical Care & Pain Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.accpm.2024.101445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 fran\u00e7aise d'anesth\u00e9sie et de r\u00e9animation (Sfar). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101445"}}